Next Article in Journal
Therapeutic Efficacy of CD34-Derived Allogeneic Dendritic Cells Engineered to Express CD93, CD40L, and CXCL13 in Humanized Mouse Models of Pancreatic Cancer
Next Article in Special Issue
Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
Previous Article in Journal
A Prospective Cohort Study of Primary Dengue Virus Infection in Medellín, Colombia
Previous Article in Special Issue
The Role of Anti-Interferon-α Autoantibodies in Severe COVID-19: Implications for Vaccination Prioritization
 
 
Systematic Review

Article Versions Notes

Vaccines 2025, 13(7), 747; https://doi.org/10.3390/vaccines13070747
Action Date Notes Link
article pdf uploaded. 12 July 2025 11:23 CEST Version of Record https://www.mdpi.com/2076-393X/13/7/747/pdf-vor
article supplementary file uploaded. 12 July 2025 11:23 CEST - https://www.mdpi.com/2076-393X/13/7/747#supplementary
article pdf uploaded. 12 July 2025 12:39 CEST Updated version of record https://www.mdpi.com/2076-393X/13/7/747/pdf-vor
article xml file uploaded 15 July 2025 11:49 CEST Original file -
article xml uploaded. 15 July 2025 11:49 CEST Update https://www.mdpi.com/2076-393X/13/7/747/xml
article pdf uploaded. 15 July 2025 11:49 CEST Updated version of record https://www.mdpi.com/2076-393X/13/7/747/pdf
article html file updated 15 July 2025 11:51 CEST Original file https://www.mdpi.com/2076-393X/13/7/747/html
Back to TopTop